EntryPoint Capital’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $273K | Sell |
18,438
-710
| -4% | -$10.5K | 0.14% | 327 |
|
|
2025
Q1 | $343K | Sell |
19,148
-1,452
| -7% | -$26K | 0.16% | 256 |
|
|
2024
Q4 | $359K | Buy |
+20,600
| New | +$359K | 0.15% | 260 |
|
|
2024
Q2 | – | Sell |
-4,101
| Closed | -$31.6K | – | 1628 |
|
|
2024
Q1 | $31.6K | Buy |
+4,101
| New | +$31.6K | 0.03% | 937 |
|